350 Odcinki

  1. Episode 208: A CEO's arrest, Pfizer's big deal, & Covid on the rise

    Opublikowany: 12.05.2022
  2. Episode 207: Succession at Biogen, surprises at Vertex, & a potential superspreader dinner

    Opublikowany: 5.05.2022
  3. Episode 206: How cancer-killing cell therapies work, biotech's endless downturn, & an FDA conundrum

    Opublikowany: 28.04.2022
  4. Episode 205: An ominous biotech deal, vaccines for kids, & 'breakthrough' devices

    Opublikowany: 21.04.2022
  5. Episode 204: Leana Wen on the pandemic's new normal and whether Twitter is real life

    Opublikowany: 14.04.2022
  6. Episode 203: What's next for Roche, a debate over second boosters, & Vertex's recent success

    Opublikowany: 7.04.2022
  7. Introducing: Color Code

    Opublikowany: 31.03.2022
  8. Episode 202: Helen Branswell on the pandemic, plus the next FDA debate & the perks of being a CEO

    Opublikowany: 24.03.2022
  9. Episode 201: Doing biotech in Ukraine, drug pricing déjà vu, & Covid surges overseas

    Opublikowany: 17.03.2022
  10. Episode 200: Gilead's growing pains, Covid's origins, & Theranos as prestige TV

    Opublikowany: 10.03.2022
  11. Episode 199: Biden's plans for Covid pills, the latest vaccine data, & fighting about CRISPR

    Opublikowany: 3.03.2022
  12. Episode 198: Medical racism, new Covid vaccines, & the resilience of Regeneron

    Opublikowany: 24.02.2022
  13. Episode 197: Robert Califf's FDA return, the future of CRISPR, & another vaccine delay

    Opublikowany: 17.02.2022
  14. Episode 196: Eric Lander's resignation, FDA's about-face, & Pfizer's lucrative pandemic

    Opublikowany: 10.02.2022
  15. Episode 195: Califf's sudden jeopardy, the quest for a PCSK9 pill, & Covid vaccines for kids

    Opublikowany: 3.02.2022
  16. Episode 194: Janet Woodcock on Covid antibodies, vaccines for kids, and responding to Omicron

    Opublikowany: 27.01.2022
  17. Episode 193: Jared Holz on Biotech's red tape, plus the latest billionaire science project

    Opublikowany: 20.01.2022
  18. Episode 192: Michael Gilman on the future of RNA drugs, plus #JPM22 in review and more Biogen news

    Opublikowany: 13.01.2022
  19. Episode 191: Craig Spencer on the Omicron surge + biotech in 2022, & the Elizabeth Holmes verdict

    Opublikowany: 6.01.2022
  20. Episode 190: Covid in 2022, J.P. Morgan bows to pressure, & the year in review

    Opublikowany: 16.12.2021

8 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site